(Q37081084)

18 August 2017

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker (English)

1 reference

18 August 2017

1 reference

1 reference

A Misawa

1

1 reference

18 August 2017

S Tanaka

2

1 reference

18 August 2017

S Yagyu

3

1 reference

18 August 2017

K Tsuchiya

4

1 reference

18 August 2017

T Iehara

5

1 reference

18 August 2017

T Sugimoto

6

1 reference

18 August 2017

H Hosoi

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

British Journal of Cancer

18 August 2017

1 reference

18 August 2017

100

1 reference

18 August 2017

2

1 reference

18 August 2017

399-404

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604887

18 August 2017

0 references

cites work

Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

The role of RASSF1A methylation in cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2634715

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604887

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604887

DNA methylation in serum of breast cancer patients: an independent prognostic marker

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19165202

12 December 2020

inferred from PubMed ID database lookup

Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19165202

12 December 2020

inferred from PubMed ID database lookup

Methylation of tumor-suppressor genes in neuroblastoma: The RASSF1A gene is almost always methylated in primary tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19165202

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6604887

1 reference

release_3nanag3sx5c5tbyegrlcp6d7uq

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3nanag3sx5c5tbyegrlcp6d7uq

24 November 2022

mapped directly with Wikidata item

1 reference

18 August 2017

1 reference